Lopinavir/Ritonavir Mylan European Union - English - EMA (European Medicines Agency)

lopinavir/ritonavir mylan

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Nasusaf 137 micrograms/50 micrograms per actuation nasal spray, suspension Ireland - English - HPRA (Health Products Regulatory Authority)

nasusaf 137 micrograms/50 micrograms per actuation nasal spray, suspension

teva b.v. - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - fluticasone, combinations

Fluticasone propionate 50micrograms/actuation nasal spray, suspension United Kingdom - English - myHealthbox

fluticasone propionate 50micrograms/actuation nasal spray, suspension

beecham group plc - benzalkonium chloride - nasal spray, suspension - 0.5 mg - nasal preparations, corticosteroids - this medicine provides symptomatic treatment of allergic rhinitis due to hay fever or other airborne allergens (such as dust mites, mould spores, or animal dander).

Nasorinit 137 micrograms/50 micrograms per actuation nasal spray, suspension Ireland - English - HPRA (Health Products Regulatory Authority)

nasorinit 137 micrograms/50 micrograms per actuation nasal spray, suspension

clonmel healthcare ltd - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - fluticasone, combinations